ArticlePharmacoepidemiology and drug safety2026
Comparative Effectiveness of Oral Fluoropyrimidines Versus FOLFOX as Adjuvant Therapy for Stage III Colon Cancer: A Retrospective Cohort Study Using Overlap-Weighted Restricted Mean Survival Time Analysis.
Shih-Feng Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.